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CONTROLLED RELEASE
NANOPARTICULATE MATTER DELIVERY
SYSTEM
CLAIM TO PRIORITY
This non-provisional application claims priority to pro-
visional application No. 61/614,120 filed on Mar. 22, 2012,
the entire disclosure being hereby incorporated by reference.
BACKGROUND
Thepresent disclosure relates generally to a liquid agent
delivery system and, moreparticularly, to an electronically
controlled release system to a deliver a liquid agent.
Conventional liquid agent delivery devices, such as a
transdermal medical device, typically consist of a medicated
adhesive patch that is placed on a patient’s skin or wound to
deliver medication. The medication is then absorbed through
the skin and into the bloodstream to treat the patient.
Conventional transdermal medical devices, however, are
incapable of controlling the dosage applied to the skin or
wound. For example, the medication may be released from
the patch at an uncontrollable rate. Furthermore, the dosage
of the medication is released regardless of the biometrics of
the patient.
SUMMARY
In an exemplary embodiment, a controlled release nano-
particulate matter delivery system comprises a plurality of
thermoresponsive modules containing a respective nanopar-
ticulate matter. Each thermoresponsive module is selectively
operable in at least one of a heating mode that releases the
nanoparticulate matter and a cooling mode that inhibits
release of the nanoparticulate matter. The delivery system
further comprises a control module in electrical communi-
cation with the plurality of thermoresponsive modules. The
control module is configured to determine a temperature of
each thermoresponsive module and to select the at least one
heating mode and the cooling mode based on the tempera-
ture.
In another embodiment, a thermoresponsive module to
release a nanoparticulate matter comprises a thermoelectric
device and a hydrocomposite carrier. The thermoelectric
device includes a variable temperature surface, and is selec-
tively operable in at least one of a heating mode to heat the
surface and a cooling mode to cool the surface. The hydro-
composite carrier is configured to deliver the nanoparticulate
matter based on the temperature of the variable temperature
surface.
In still another embodiment, a method of releasing nano-
particulate matter contained in a thermoresponsive polymer
comprises determining a desired release rate at which to
release the nanoparticulate matter, and determining a desired
temperature at which the nanoparticulate matter is released
at the desired release rate. The method further comprises
determining an actual temperature of the thermoresponsive
polymer, and comparing the actual temperature to the
desired temperature. The method further includes adjusting
the actual temperature of the thermoresponsive polymer to
control the release ofthe nanoparticulate matter based on the
comparison between the actual temperature and the desired
temperature.
BRIEF DESCRIPTION OF THE DRAWINGS
For a more complete understanding of this disclosure,
reference is now madeto the following brief description,
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taken in connection with the accompanying drawings and
detailed description, wherein like reference numerals repre-
sent like parts:
FIG. 1 is a block diagram of a controlled release nano-
particulate matter delivery system according to an exem-
plary embodimentof the disclosure;
FIG. 2 illustrates a diagram of hydrocomposite carrier
including a thermoresponsive polymer containing nanopar-
ticulate matter according to an exemplary embodiment of
the disclosure;
FIG. 3A is a block diagram illustrating a thermorespon-
sive module according to an exemplary embodiment of the
disclosure;
FIG. 3B is an exploded view of a thermoresponsive
moduleillustrated in FIG. 3A;
FIG.4A is a diagram of a thermoelectric device operating
in a first mode according to an exemplary embodimentofthe
disclosure;
FIG.4Bis a diagram of a thermoelectric device operating
in a second modeaccording to an exemplary embodimentof
the disclosure;
FIG. 5 illustrates a controlled release nanoparticulate
matter delivery system according to another exemplary
embodiment of the disclosure;
FIG.6 is a flow diagram illustrating a methodofreleasing
nanoparticulate matter according to an exemplary embodi-
mentof the disclosure;
FIG. 7 is a flow diagram illustrating another method of
releasing nanoparticulate matter according to an exemplary
embodiment of the disclosure; and
FIG.8 is a flow diagram illustrating still another method
of releasing nanoparticulate matter according to an exem-
plary embodimentof the disclosure.
DETAILED DESCRIPTION
It will be appreciated that for simplicity and clarity of
illustration, where appropriate, reference numerals have
been repeated amongthe different figures to indicate corre-
sponding or analogous elements. In addition, numerous
specific details are set forth in order to provide a thorough
understanding of the embodiments described herein. How-
ever, it will be understood by those of ordinary skill in the
art that the embodiments described herein can be practiced
without these specific details. In other instances, methods,
procedures and components have not been described in
detail so as not to obscure the related relevant feature(s)
being described. Also, the description is not to be considered
as limiting the scope of the embodiments described herein.
Referring now to FIG.1, a block diagram of a controlled
release nanoparticulate matter delivery system 100 accord-
ing to an exemplary embodiment of the disclosure. The
delivery system 100 includes a plurality of thermorespon-
sive modules 102 and a control module 104. The thermo-
responsive modules 102 contain a respective nanoparticulate
matter. The thermoresponsive modules 102 may contain the
same type of nanoparticulate matter, or may contain a
different type of nanoparticulate matter. In addition, the
delivery system may include a combination of thermo-
responsive modules 102, each containing different types of
nanoparticulate matter. The nanoparticulate matter may
include a therapeutic nanoparticulate matter including, but
not limited to, antimicrobial agents, analgesics, and growth
hormones. It is to be appreciated that the nanoparticulate
matter is not limited to any particular mass and/or density of
the nanoparticulate matter. In at least one embodiment, the
nanoparticulate matter is an aqueous therapeutic nanopar-
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ticulate matter, such as a liquid-based medication. The
liquid-based medication may be introduced to the skin or
wound of a subject, such as a human patient for example,
whereit is absorbed into the bloodstream.
Referring further to FIG. 1, each thermoresponsive mod-
ule 102 is configured to selectively operate in a heating
mode and a cooling mode. The heating mode releases the
nanoparticulate matter from the thermoresponsive module
102 so it may be delivered to the skin or a wound. The
cooling mode, however, inhibits release of the nanoparticu-
late matter such that it is withheld in thermoresponsive
module 102.
More specifically, the thermoresponsive module 102
includes a housing 106, and a hydrocomposite carrier 108
that contains the nanoparticulate matter. The hydrocompos-
ite carrier 108 is disposed in the housing 106 such that a
surface of the hydrocomposite carrier 108 is capable of
contacting skin or wound. When operating in the heating
mode, the nanoparticulate matteris released from the hydro-
composite carrier 108 and permeates there through to con-
tact the skin or wound. Whenoperating in the cooling mode,
however, the nanoparticulate matter is inhibited from per-
meating through the hydrocomposite carrier 108, as dis-
cussed in greater detail below.
Referring to FIG. 2, the hydrocomposite carrier 108 may
include a thermally responsive composite hydrogel material
110. In at least one example, the composite hydrogel mate-
rial 108 comprises one or more thermoresponsive polymers
112 containing an aqueous nanoparticulate matter 114, a
photo-initiator, such as for example Irgacure 2959, and a
matrix polymer. In at least one embodiment of the disclo-
sure, the thermoresponsive polymer 112 is formed from
Poly[N-isopropylacrylamide-co-acrylamide] (PNIPAM-
AA).
The thermoresponsive polymers 112 i.e., the PNIPAM-
AAm 112, experience a phase change based on the tempera-
ture of the polymer 112. More specifically, when the ther-
moresponsive polymer 112 is below afirst temperature, 1.e.,
a lowercritical solution temperature (LCST), the PNIPAM-
AAm 112 is hydrophilic. Accordingly, the PNIPAM-AAm
112 inhibits the release of the aqueous nanoparticulate
matter 114 and allows the thermoresponsive polymer 112 to
remain loaded. The hydrogel 110 may be exposed to heat,
which thereby heats the thermoresponsive polymer 112.
Whenthe temperature of the thermoresponsive polymer 112
exceeds the LCST, the PNIPAM-AAm 112 becomes hydro-
phobic and rejects the aqueous nanoparticulate matter 114
into the surrounding hydro gel 110. Accordingly, the nano-
particulate matter 114 permeates through the hydrogel 110
whereit contacts the skin. Thermal insulation agents may be
added to the hydrogel 110 to vary the LCST. For example,
acrylamide may be addedto the hydrogel 110 to increase the
LCSTofthe PNIPAM-AAm 112 from about 80° F. to about
100° F., thus reducing the possibility that normal contact
with skin or wound wouldnot create enough heat to activate
the hydrophobic state of the PNIPAM-AAm 112.
When the thermoresponsive polymer 112 is heated con-
tinuously at a temperature above the LCST, the nanopar-
ticulate matter 114 experiences three types ofrelease phases.
An initial burst phase, a sustained burst phase, and a plateau
release phase. The initial burst is completed in approxi-
mately the first hour from which the hydrophobicstate of the
thermoresponsive polymer 112 is activated. The initial burst
phase releases the nanoparticulate matter 114 at the highest
rate with respect to the three release phases. The sustained
burst phase lasts approximately 1-8 hours and releases the
nanoparticulate matter 114 at rate less than the initial burst
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phase. Theplateau release phase releases the nanoparticulate
matter 114 atrate less than eachoftheinitial burst phase and
the sustained burst phase, and may commence when the
supply of nanoparticulate matter 114 stored in the thermo-
responsive module 102 nears complete depletion. By selec-
tively exposing the hydrogel 110 to cycles of heating and
cooling, the amount of nanoparticulate matter 114 released
during each of the three phases, and in particular the initial
burst phase, may be controlled to provide a “uniform dos-
ing” of the nanoparticulate.
The control module 104 is in electrical communication
with each of the thermoresponsive modules 102. In general,
the term “module”, as used herein, refers to logic embodied
in hardware or firmware, or to a collection of software
instructions, written in a programming language including,
but not limited to, Java, C, or assembly, and which is
executed by a microprocessor. Oneor more software instruc-
tions in the modules may be embedded in firmware, suchas,
for example, in an EPROM, and/or stored in any type of
non-transitory computer-readable medium or other storage
device. In addition, the control module 104 may include a
battery powered mobile field programmable gate array,
which allows the delivery system 100 to be easily coupled
to the subject, withoutrestricting the subject’s mobility. The
control module 104 may further be programmed with a
desired dosing profile. That is, the memory of the control
module 104 may be stored with one or more desired profiles
indicative of the release rate, release time, release amount,
etc., of the nanoparticulate matter 114 stored in one or more
thermoresponsive modules 102. Accordingly, the release of
the nanoparticulate matter 114 may be controlled according
to the respective dosing profile.
In at least one embodiment, the control module may
control one thermoresponsive module 102 individually with
respect to a different thermoresponsive module 102. The
control module 104 may also control groups of thermo-
responsive modules 102 individually from different groups,
or may control all of the thermoresponsive modules 102 at
one time. The control module 104 may be configured to
determine a temperature of each thermoresponsive module
102 and/or one or more biometric conditions, and to select
at least one heating mode or cooling mode based on the
temperature and/or biometric conditions. In addition, the
control module 104 maycontrol the dosing amounts, release
rates and/or release times of the nanoparticulate matter 114,
as discussed in greater detail below.
Referring now to FIGS. 3A-3B,a thermoresponsive mod-
ule 102 is illustrated according to an exemplary embodiment
of the disclosure. The thermoresponsive module 102
includes a housing 106, a tray 116, a thermoelectric device
118, and a hydrocomposite carrier 108. The housing 106
includes a plurality of walls 120 defining an opening that
extends betweena first end of the housing and a second end
opposite the first end. At least one wall 120' has a length
shorter than the remaining walls to define a clearance
between the at least one wall 120' and the first end. The
housing further includes a ledge 122 extending from an
inner surface of the housing into the opening. The ledge 122
defines a first opening and a second opening. The first
opening extends between the second end andthe ledge 122.
The second opening is larger than the first opening, and
extends between the ledge 122 andthe first opening. In at
least one exemplary embodiment, the housing is formed of
poly(methyl methacrylate) (PMMA).
The tray 116 includesa plurality of sides 124 defining an
open bottom and a solid top surface 126 opposite the open
bottom to define an inner cavity. A base 128 surrounds the
US 9,522,241 B2
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open bottom. The tray 116 is disposed at the second opening
of the housing 106 such that the base 128 supports the
housing 106, and the sides 124 of the tray 116 extend into
the first opening. The tray 116 is formed from a thermally
conductive material including, but not limited to, aluminum
and steel. Accordingly, the tray 116 may transfer heat
received at one or more of the sides 124 into the internal
cavity. In at least one embodiment, the tray 116 may be
removed from the thermoresponsive module 102. Accord-
ingly, the thermoresponsive module 102 may be cleaned and
sterilized, and the tray 116 may be reloaded with nanopar-
ticulate matter before being replaced.
The thermoelectric device 118 includes at least one ther-
mal surface 130, 130' that varies in temperature based on an
operating mode of the thermoelectric device 118. More
specifically, the thermoelectric device 118 is configured to
operate in at least one of a heating mode and a cooling mode
based onthe flow ofthe current. When current flowsin a first
direction (€.g., 17.47) through the thermoelectric device 118,
the thermal surface 130 is heated such that the thermoelec-
tric device 118 emits heat therefrom as illustrated in FIG.
4A. However, when current flows in a second direction
opposite the first direction (e.g., icgoz), the thermal surface
130 is cooled as illustrated in FIG. 4B. In at least one
embodiment, the control module 104 is electrically con-
nected to the thermoelectric device 118. The control module
104 generates a first voltage having a first polarity, which
thereby induces the current to flow in the first direction. To
generate the current flow in the seconddirection, the control
module 104 generates a voltage having an oppositepolarity.
In at least one embodiment, the thermoelectric device 118 is
a thermoelectric Peltier device, which is well-known by
those of ordinary skill in the art and operates according to a
Peltier effect generally described above.
The thermoelectric device 118 is disposed at the first
opening and is supported by the ledge 122 such that the
thermal surface 130 is in thermal communication with the
top surface 126 of the tray 116 through a thermal sensor.
Accordingly, when the thermoelectric device 118 operates in
the heating mode, heat from the top surface 126 of the tray
116 is transferred into the inner cavity. When the thermo-
electric device 118 operates in the cooling mode, however,
the top surface 126 of the tray 116 is cooled, thereby cooling
the inner cavity.
The hydrocomposite carrier 108 is disposed in the cavity
of the tray 116 to deliver the nanoparticulate matter 114
therefrom. As discussed in detail above, the composite
hydrogel material 110 comprises one or more thermorespon-
sive polymers 112 containing the aqueous nanoparticulate
matter 114. The nanoparticulate matter 114 is released based
on the temperature of the thermoresponsive polymers 112.
By disposing the hydrocomposite carrier 108 in the inner
cavity of the tray 116, the temperature of the thermorespon-
sive polymers 112 may be selectively varied via the ther-
moelectric device 118 to selectively release the nanoparticu-
late matter 114.
In at least one embodiment, the thermoresponsive module
102 may further include a thermal sensor 132 interposed
between the thermoelectric device 118 and the top surface
126 ofthe tray 116. The thermal sensor 132 mayinclude, but
is not limited to, a thermocouple. The thermal sensor 132
maybein electrical communication with the control module
104 to output a voltage signal in response to the heat to
indicate a temperature at the thermoelectric device 118. The
control module 104 may include memory that stores a
release temperature value, i.e., the LCST, to determine the
temperature at which the thermoresponsive polymer 112
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releases the nanoparticulate matter 114. During operation,
the thermal sensor 132 may output a voltage indicative ofthe
actual temperature of the thermoresponsive polymer 112.
The control module 104 may compare the actual tempera-
ture to the stored release temperature, and may control the
flow of current (i¢goz OF igz47) to the thermoelectric device
118. Accordingly, the temperature of the thermoresponsive
polymer 112 may be varied, and the release of the nanopar-
ticulate matter 114 from one or more of the thermorespon-
sive modules 102 may be controlled.
Referring now to FIG. 5, a controlled release nanopar-
ticulate matter delivery system 100 is illustrated according
to another exemplary embodiment of the disclosure. The
controlled release nanoparticulate matter 114 delivery sys-
tem 100 illustrated in FIG. 5 includes aflexible bandage 134
that includes a plurality of thermoresponsive modules 102,
which can release multiple medications on any time sched-
ule, ie., at any delivery time. As mentioned above, the
release of the nanoparticulate matter 114 may be based on a
desired dosing profile programmed in the control module
104 and/or stored in a memory. The memory may be
integrated in the control module 104 and/or may be con-
nected in electrical communication with the control module
104 via a removable memory storage device.In at least one
example, a first thermoresponsive module 102' may be
loaded with a first nanoparticulate matter, such as an anti-
microbial, and may be released every hour. A second ther-
moresponsive module 102" may be loaded with a second
different nanoparticulate matter, such as a growth hormone,
and maybereleased every four hours. A third thermorespon-
sive module 102' may be loaded with a third nanoparticulate
matter, such as a pain killer, and may be released continu-
ously without interruption. In addition, the thermorespon-
sive module 102, or at least a portion of the thermorespon-
sive module 102, such as tray discussed in detail above, may
be removed from the bandage. Accordingly, the bandage 134
and/or the thermoresponsive module 102 may be cleaned
and sterilized. In addition, the thermoresponsive module 102
maybe reloaded with nanoparticulate and then returned to
the bandage 134 without compromising the integrity of one
or more electrical wires, which are discussed in greater
detail below.
The width of the bandage extends along the Y-axis and
maybe fixed by the number of thermoresponsive modules
102 in a strip. The length of the bandage extends along the
X-direction and may be customizable to the size of a
treatment site, i.e., an area of the skin to be treated. Each
module may be wiredlaterally in the Y-direction to define
one or more strips, i.e., rows, extending several modules
long. Each of these strips is independently wired so the
bandage may becut along a cutting axis (A), which extends
along the Y-axis and in betweenstrips. Accordingly, the size
of the bandage may be customized without compromising
the integrity of the wiring.
The delivery system 100 may further includeat least one
sensor 136 in electrical communication with the control
module 104. The sensors 136 may determine at least one
biometric condition of the subject that is to receive the
nanoparticulate matter. The biometric condition includes,
but is not limited to, body temperature, body perspiration,
bodyvibration, breathing, heart rate and sound. Accordingly,
the control module 104 controls at least one thermorespon-
sive module 102 to release the nanoparticulate matter in
responseto the detection of at least one biometric condition.
For example, a sensor 136 may be coupled to the skin or
wound of the subject, and may output a temperature signal
indicative of the subject’s body temperature. Based on the
US 9,522,241 B2
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temperature signal, the control module 104 may determine
the subject has a fever, and maytherefore controlat least one
thermoresponsive module 102 loaded with fever-reducing
medication to release the medication. In another embodi-
ment, a plurality of sensors 136 may each detect a different
respective biometric condition. Accordingly, the control
module 104 may control individual thermoresponsive mod-
ules 102 to release a particular medication that treats the
respective detected biometric condition.
Embodiments of the delivery system 100 may further
include one or more sub-systems including, but not limited
to, a thermal management system, an exudate removal
system, and a graphic user interface (GUI). The thermal
management system may be coupled with the bandage
and/or one or more thermoresponsive modules to remove
heat from the system. The thermal management system may
include, but is not limited to, one or more heat sinks and a
liquid cooling system. The liquid cooling system may be in
electrical communication with the control module 104, and
maybe controlled according to the one or more sensors that
detect a temperature associated with the delivery system 100
The exudate removal system may be provided to remove
bodily fluids released from a woundthat is to be treated
using the delivery system 100. The exudate removal system
may include a piezoelectric pump and one or more micro-
channels. The pump may be in electrical communication
with the control module to remove access bodily fluids from
the delivery system via the microchannels.
The GUI maybe included with the delivery system 100
and may provide various information to a subject and/or a
person treating the subject. In at least one embodiment, the
GU]is in electrical communication with the control module,
and may provide information including, but not limited to,
the type of nanoparticulate matter loaded in a particular
thermoresponsive module, the amount of nanoparticulate
matter remaining in a particulate module, the temperature of
the subject and/or the thermoresponsive modules, informa-
tion from the biometric sensors, the dosing times and/or
release rates set for each thermoresponsive module, which
thermoresponsive modules are actively releasing nanopar-
ticulate matter, etc. In addition, the GUI mayreceive direct
inputs that control the operation of the delivery system
including, but not limited to, dosing times, release rates,
enable/disable ofparticulate thermoresponsive modules, etc.
Accordingly, precise control of the thermoresponsive mod-
ule may be conveniently achieved.
Referring now to FIG. 6, a flow diagram illustrates a
methodof releasing nanoparticulate matter according to an
exemplary embodimentof the disclosure. At operation 600,
a desired release rate at which to release nanoparticulate
matter is determined. At operation 602, a release tempera-
ture is determined. The release temperature may include, for
example, the LCST at which the thermoresponsive polymer
becomes hydrophobic andreleases the nanoparticulate mat-
ter contained therein. The thermoresponsive polymer is
heated above the release temperature at operation 604.
Accordingly, the nanoparticulate matter may be released
from the nanoparticulate matter and may ultimately be
delivered to a target area of the skin. At operation 606, the
actual temperature of the thermoresponsive polymer is
determined. The actual temperature is compared to the
release temperature at operation 608. At operation 610, the
heat provided to the thermoresponsive polymer may be
adjusted and/or cut off based on the comparison in order to
control the release rate of the nanoparticulate matter, and the
operation ends. It is appreciated that the method described
above is at least one example of releasing nanoparticulate
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matter, and other methods of controlling the release or
inhibiting the release of the nanoparticulate matter based on
the temperature of the thermoresponsive polymer may be
realized. Further, it is appreciated that the method may be
repeated for the duration of a dosageprofile.
Referring now to FIG. 7, a flow diagram illustrates
another method of releasing nanoparticulate matter con-
tained in a thermoresponsive polymer. At operation 700, a
desired release rate for releasing the nanoparticulate matter
from the thermoresponsive polymeris determined. At opera-
tion 702, a desired temperature of the thermoresponsive
polymer at which the nanoparticulate matter is released at
the desired release rate is determined. A determination ofthe
actual temperature, i.e., real-time temperature, of the ther-
moresponsive polymer is performed at operation 704. The
actual temperature may then be compared to the desired
temperature at operation 706. Based on the comparison, the
actual temperature of the thermoresponsive polymer may be
adjusted to control the release of nanoparticulate matter
therefrom at operation 708, and the method ends. The actual
temperature of the thermoresponsive polymer may control
according to operation of the controlled release nanopar-
ticulate matter delivery system described in detail herein.
Moreover, it is appreciated that the method may be repeated
for the duration of a dosageprofile.
Turning now to FIG. 8, a flow diagram illustrates a
method of releasing nanoparticulate matter contained in a
thermoresponsive module according to at least one exem-
plary embodiment. More specifically, a type of nanoparticu-
late contained in one or more thermoresponsive modules is
determined at operation 800. For example, one or morefirst
thermoresponsive modules may contain fever reducing
nanoparticulates, while one or more second thermorespon-
sive modules may contain antimicrobial nanoparticulates. At
operation 802, one or more biometric conditions corre-
sponding to a respective nanoparticulate matter are deter-
mined. For example, the fever reducing nanoparticulate may
correspond to a biometric condition, such as a fever detected
by excessive body temperature, while the antimicrobial
nanoparticulate matter may correspond to formation of an
infection detected by one or more sensors. At operation 804,
one or more biometric conditions are detected. As men-
tioned above, the biometric condition may be detected by
one or more sensors located near and/or coupled to the
subject. In response to detecting the biometric condition,
controlled release of the corresponding nanoparticulate mat-
ter is initiated, and the method ends. The release of the
nanoparticulate matter in response to detecting the biometric
condition is controlled according to at least one embodiment
of the controlled release nanoparticulate matter delivery
system described in detail above.
While the disclosure has been described with reference to
a preferred embodiment or embodiments, it will be under-
stood by those skilled in the art that various changes may be
made and equivalents may be substituted for elements
thereof without departing from the scope of the disclosure.
In addition, many modifications may be made to adapt a
particular situation or material to the teachings of the
disclosure without departing from the essential scope
thereof. Therefore, it is intended that the disclosure not be
limited to the particular embodiment disclosed as the best
mode contemplated for carrying out this disclosure, but that
the disclosure will include all embodiments falling within
the scope of the appended claims.
Whatis claimedis:
1. A thermoresponsive module to release a nanoparticu-
late matter, comprising:
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control module configured to generate a first voltage
having a first polarity that induces current to flow in a
first direction and to generated second voltage having a
second polarity that induces current to flow in a second
direction opposite the first direction in response to a
second voltage polarity;
a thermoelectric device in signal communication with the
control module and including a variable temperature
surface, the thermoelectric device selectively operable
in at least one of a heating mode to actively heat the
variable temperature surface when the current flows in
the first direction, and a cooling mode to cool the
variable temperature surface when the current flows in
the second direction; and
a hydrocomposite carrier to deliver the nanoparticulate
matter therefrom based on the temperature of the
variable temperature surface.
2. The thermoresponsive module of claim 1, wherein the
hydrocomposite carrier includes a thermoresponsive poly-
10
15
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mer that contains the nanoparticulate matter and that is
configured to selectively release the nanoparticulate matter
based on a temperature generated by thermoelectric device.
3. The thermoresponsive module of claim 2, wherein the
thermoresponsive polymerretains the nanoparticulate mat-
ter therein when existing at a first temperature range and
releases the nanoparticulate matter therefrom when existing
at a temperature exceeding the first temperature range.
4. The thermoresponsive module of claim 3, wherein the
thermoresponsive polymer is formed from Poly[N-isopro-
pylacrylamide-co-acrylamide] (PNIPAM-AAm).
5. The thermoresponsive module of claim 4, further
comprising a thermal sensor configured to output a voltage
signal indicating a temperature at the thermoelectric device.
6. The thermoresponsive module of claim 1, wherein the
thermoelectric device is a Peltier device.
* * * * *
